Direct Detection of Rifampin-Resistant Mycobacterium tuberculosis in Respiratory Specimens by PCR-DNA Sequencing

ABSTRACT This study evaluated the feasibility of a molecular strategy based on identification of Mycobacterium tuberculosis by IS6110 PCR or Cobas Amplicor PCR, and rpoB PCR-DNA sequencing of the 81-bp rifampin resistance determining region (RRDR) for direct detection of rifampin resistance in respiratory specimens. A collection of 2,138 respiratory specimens and 352 nonduplicate M. tuberculosis isolates (including 233 isolates from the evaluated respiratory specimens and an additional collection of 119 stored isolates) from Southern China was investigated. Using culture as the reference test, the overall diagnostic sensitivities of an acid-fast bacillus (AFB) smear, Cobas Amplicor PCR, IS6110 PCR were 54.5% (156 of 286), 86.7% (248 of 286), and 89.2% (255 of 286), respectively. The sensitivities of the rpoB PCR for the specimens with positive AFB smears and with positive PCR results in the IS6110 PCR and/or Cobas Amplicor PCR were 100% (156 of 156) and 92.3% (239 of 259), respectively. Of the 352 nonduplicate M. tuberculosis isolates, the agar proportion method for rifampin reported 39 resistant strains. Full agreement (352 of 352) was found with the agar proportion method and the genotype inferred from the rpoB DNA sequencing data for rifampin. Thirty-nine mutations of nine distinct kinds, eight point mutations, and one deletion within the RRDR were found in the 39 resistant strains. For the direct DNA sequencing performed on rpoB PCR-positive respiratory specimens, the concordance with the agar proportion method and the subsequent PCR-sequencing for the culture isolate was 100%. This strategy has potential application for direct and rapid diagnosis of rifampin-resistant M. tuberculosis in IS6110 PCR or Cobas Amplicor PCR-positive respiratory specimens.

[1]  A. Telenti,et al.  Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level , 1997, Journal of clinical microbiology.

[2]  J. Musser,et al.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[3]  Sang-Nae Cho,et al.  rpoB Genotypes of Mycobacterium tuberculosis Beijing Family Isolates from East Asian Countries , 2002, Journal of Clinical Microbiology.

[4]  K. Yuen,et al.  Comparison of two automated DNA amplification systems with a manual one-tube nested PCR assay for diagnosis of pulmonary tuberculosis , 1997, Journal of clinical microbiology.

[5]  E. Bruck,et al.  National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.

[6]  D. Persing,et al.  Evaluation of a polymerase chain reaction-based universal heteroduplex generator assay for direct detection of rifampin susceptibility of Mycobacterium tuberculosis from sputum specimens. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  N. Binkin,et al.  Determinants of drug-resistant tuberculosis: analysis of 11 countries. , 2001, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[8]  L. Finelli,et al.  Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995. , 1998, International journal of epidemiology.

[9]  V Sintchenko,et al.  Mutations in rpoB gene and rifabutin susceptibility of multidrug-resistant Mycobacterium tuberculosis strains isolated in Australia. , 1999, Pathology.

[10]  S. Kohno,et al.  Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis. , 1998, The Journal of antimicrobial chemotherapy.

[11]  C. Abe,et al.  Mutations in the rpoB Gene of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated Mostly in Asian Countries and Their Rapid Detection by Line Probe Assay , 1999, Journal of Clinical Microbiology.

[12]  Zhong-yi Hu,et al.  Rapid Detection of rpoB Gene Mutations in Rifampin-Resistant Mycobacterium tuberculosis Isolates in Shanghai by Using the Amplification Refractory Mutation System , 2003, Journal of Clinical Microbiology.

[13]  S. Levidiotou,et al.  Four-Year Experience of Use of the Cobas Amplicor System for Rapid Detection of Mycobacterium tuberculosis Complex in Respiratory and Nonrespiratory Specimens in Greece , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[14]  J. Bayona,et al.  Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  P. Coloe,et al.  Bacteriological and Molecular Analysis of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated in Australia , 1999, Journal of Clinical Microbiology.

[16]  A. Telenti,et al.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis , 1993, The Lancet.

[17]  K. Kam,et al.  Trends in multidrug-resistant Mycobacterium tuberculosis in relation to sputum smear positivity in Hong Kong, 1989-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  A. Zaha,et al.  Mutations in the rpoB Gene of Multidrug-Resistant Mycobacterium tuberculosis Isolates from Brazil , 2000, Journal of Clinical Microbiology.

[19]  W. Yam,et al.  Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis , 2004, Journal of Clinical Pathology.

[20]  F. Drobniewski,et al.  A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampicin resistance in Mycobacterium tuberculosis. , 2000, Journal of medical microbiology.

[21]  Honghai Wang,et al.  Mutations in the rpoB Gene of Multidrug-Resistant Mycobacterium tuberculosis Isolates from China , 2003, Journal of Clinical Microbiology.

[22]  K. Yuen,et al.  Direct Detection of Mycobacterium tuberculosis in Respiratory Specimens Using an Automated DNA Amplification Assay and a Single Tube Nested Polymerase Chain Reaction (PCR) , 1998, Clinical chemistry and laboratory medicine.

[23]  F. Drobniewski,et al.  The rapid diagnosis of isoniazid and rifampicin resistance in Mycobacterium tuberculosis--a molecular story. , 1998, Journal of medical microbiology.

[24]  V. Cheng,et al.  Direct detection of Mycobacterium tuberculosis in clinical specimens using single-tube biotinylated nested polymerase chain reaction-enzyme linked immunoassay (PCR-ELISA). , 2004, Diagnostic microbiology and infectious disease.

[25]  K. Yuen,et al.  Detection of katG Ser315Thr substitution in respiratory specimens from patients with isoniazid-resistant Mycobacterium tuberculosis using PCR-RFLP. , 2003, Journal of medical microbiology.

[26]  L. Riley,et al.  Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes. , 1997, Chest.

[27]  M. Torres,et al.  Direct Detection of Rifampin- and Isoniazid-Resistant Mycobacterium tuberculosis in Auramine-Rhodamine-Positive Sputum Specimens by Real-Time PCR , 2004, Journal of Clinical Microbiology.

[28]  M. L. Ricci,et al.  rpoB Mutations in Multidrug-Resistant Strains of Mycobacterium tuberculosis Isolated in Italy , 1999, Journal of Clinical Microbiology.

[29]  S. Niemann,et al.  Frequency of rpoB Mutations Inside and Outside the Cluster I Region in Rifampin-Resistant Clinical Mycobacterium tuberculosis Isolates , 2001, Journal of Clinical Microbiology.

[30]  W. Haas,et al.  Universal pattern of RpoB gene mutations among multidrug-resistant isolates of Mycobacterium tuberculosis complex from Africa. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[31]  Christopher Dye,et al.  Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 2001, The New England journal of medicine.

[32]  Igor Mokrousov,et al.  Allele-Specific rpoB PCR Assays for Detection of Rifampin-Resistant Mycobacterium tuberculosis in Sputum Smears , 2003, Antimicrobial Agents and Chemotherapy.

[33]  K. Yuen,et al.  Single-tube nested PCR in the diagnosis of tuberculosis. , 1996, Journal of clinical pathology.

[34]  M. Kimerling,et al.  The risk of MDR-TB and polyresistant tuberculosis among the civilian population of Tomsk city, Siberia, 1999. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[35]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[36]  D. Aubert,et al.  Multicenter Study of a Commercial, Automated Polymerase Chain Reaction System for the Rapid Detection of Mycobacterium tuberculosis in Respiratory Specimens in Routine Clinical Practice , 2001, European Journal of Clinical Microbiology and Infectious Diseases.